Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 3 1Phase 1/2 1Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 19Leukemia 16Myelodysplastic Syndromes 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neuroblastoma 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Multiple Myeloma 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Myelomonocytic, Acute 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Congenital Abnormalities 3Sarcoma, Ewing 2Neoplasms, Plasma Cell 2Myeloproliferative Disorders 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Lymphocytic, Chronic, B-Cell 2Graft vs Host Disease 2Burkitt Lymphoma 2Anemia, Refractory, with Excess of Blasts 2Sarcoma 1Recurrence 1

Interventions

Tretinoin 12Arsenic Trioxide 7Methotrexate 5Mercaptopurine 5Cytarabine 5Idarubicin 4Mitoxantrone 3Thioguanine 2Radiotherapy 2Etoposide 2Daunorubicin 2Cyclophosphamide 2sargramostim 1merphos 1flt3 ligand protein 1Peripheral Blood Stem Cell Transplantation 1Maintenance 1Hydroxyurea 1Filgrastim 1Busulfan 1Amsacrine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Leukemia, Promyelocytic, Acute × Busulfan × Clear all
NCT00002701 2013-09-20

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
750 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡